These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 9820630)

  • 1. Pirarubicin nuclear uptake does not correlate with its induced cell death effect during reversal of multidrug resistance by quinine in human K562 and CEM leukemic cells.
    Morjani H; Belhoussine R; Lahlil R; Manfait M
    Eur J Haematol; 1998 Oct; 61(4):240-9. PubMed ID: 9820630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence for reversal of multidrug resistance by quinine in LR73 cells without alteration of nuclear pirarubicin uptake and down-regulation of mdr1 gene expression.
    Belhoussine R; Morjani H; Lahlil R; Manfait M
    Int J Cancer; 1997 Nov; 73(4):600-6. PubMed ID: 9389578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of quinine on the multiple drug resistance and intracellular distribution of pirarubicin in LR73 tumor cells: a comparative study with verapamil and S9788 by confocal laser microspectrofluorometry].
    Belhoussine R; Morjani H; Manfait M
    Bull Cancer; 1997 Apr; 84(4):343-9. PubMed ID: 9238156
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anthracycline subcellular distribution in human leukemic cells by microspectrofluorometry: factors contributing to drug-induced cell death and reversal of multidrug resistance.
    Morjani H; Millot JM; Belhoussine R; Sebille S; Manfait M
    Leukemia; 1997 Jul; 11(7):1170-9. PubMed ID: 9205008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Confocal scanning microspectrofluorometry reveals specific anthracyline accumulation in cytoplasmic organelles of multidrug-resistant cancer cells.
    Belhoussine R; Morjani H; Millot JM; Sharonov S; Manfait M
    J Histochem Cytochem; 1998 Dec; 46(12):1369-76. PubMed ID: 9815278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cellular pharmacology of lipophilic anthracyclines in human tumor cells in culture selected for resistance to doxorubicin.
    Bennis S; Faure P; Chapey C; Hu YP; Fourche J; El Yamani J; Robert J
    Anticancer Drugs; 1997 Jul; 8(6):610-7. PubMed ID: 9300576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nuclear DNA content and chromatin texture in multidrug-resistant human leukemic cell lines.
    Dufer J; Millot-Broglio C; Oum'Hamed Z; Liautaud-Roger F; Joly P; Desplaces A; Jardillier JC
    Int J Cancer; 1995 Jan; 60(1):108-14. PubMed ID: 7814142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Doxorubicin-resistant variants of human prostate cancer cell lines DU 145, PC-3, PPC-1, and TSU-PR1: characterization of biochemical determinants of antineoplastic drug sensitivity.
    David-Beabes GL; Overman MJ; Petrofski JA; Campbell PA; de Marzo AM; Nelson WG
    Int J Oncol; 2000 Dec; 17(6):1077-86. PubMed ID: 11078791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relation between MDR1 mRNA levels, resistance factor, and the efficiency of P-glycoprotein-mediated efflux of pirarubicin in multidrug-resistant K562 sublines.
    Meesungnoen J; Jay-Gerin JP; Mankhetkorn S
    Can J Physiol Pharmacol; 2002 Nov; 80(11):1054-63. PubMed ID: 12489924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The ability of verapamil to restore intracellular accumulation of anthracyclines in multidrug resistant cells depends on the kinetics of their uptake.
    Mankhetkorn S; Garnier-Suillerot A
    Eur J Pharmacol; 1998 Feb; 343(2-3):313-21. PubMed ID: 9570481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid up-regulation of mdr1 expression by anthracyclines in a classical multidrug-resistant cell line.
    Hu XF; Slater A; Wall DM; Kantharidis P; Parkin JD; Cowman A; Zalcberg JR
    Br J Cancer; 1995 May; 71(5):931-6. PubMed ID: 7734315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transport mechanisms of anthracycline derivatives in human leukemia cell lines: uptake of pirarubicin, daunorubicin and doxorubicin by K562 and multidrug-resistant K562/ADM cells.
    Nagasawa K; Takara K; Nomiyama M; Ohnishi N; Yokoyama T
    Biol Pharm Bull; 1996 Jul; 19(7):971-6. PubMed ID: 8839972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence for transcriptional control of human mdr1 gene expression by verapamil in multidrug-resistant leukemic cells.
    Muller C; Goubin F; Ferrandis E; Cornil-Scharwtz I; Bailly JD; Bordier C; Bénard J; Sikic BI; Laurent G
    Mol Pharmacol; 1995 Jan; 47(1):51-6. PubMed ID: 7838133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resistant mechanisms of anthracyclines--pirarubicin might partly break through the P-glycoprotein-mediated drug-resistance of human breast cancer tissues.
    Kubota T; Furukawa T; Tanino H; Suto A; Otan Y; Watanabe M; Ikeda T; Kitajima M
    Breast Cancer; 2001; 8(4):333-8. PubMed ID: 11791127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kinetic analysis in living cells of the inhibition of the P-glycoprotein-mediated efflux of anthracyclines by vinca alkaloids.
    Pereira E; Tarasiuk J; Garnier-Suillerot A
    Chem Biol Interact; 1998 Jul; 114(1-2):61-76. PubMed ID: 9744556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of glucosylceramide synthase on P-glycoprotein function in K562/AO2 leukemia drug-resistance cell line.
    Zhang YY; Xie KM; Yang GQ; Mu HJ; Yin Y; Zhang B; Xie P
    Int J Hematol; 2011 Mar; 93(3):361-367. PubMed ID: 21380926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The novel anthracycline annamycin is not affected by P-glycoprotein-related multidrug resistance: comparison with idarubicin and doxorubicin in HL-60 leukemia cell lines.
    Consoli U; Priebe W; Ling YH; Mahadevia R; Griffin M; Zhao S; Perez-Soler R; Andreeff M
    Blood; 1996 Jul; 88(2):633-44. PubMed ID: 8695811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation of P-glycoprotein expression and function in childhood acute leukemia: a children's cancer group study.
    Ivy SP; Olshefski RS; Taylor BJ; Patel KM; Reaman GH
    Blood; 1996 Jul; 88(1):309-18. PubMed ID: 8704189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Partial inhibition of the P-glycoprotein-mediated transport of anthracyclines in viable resistant K562 cells after irradiation in the presence of a verapamil analogue.
    Mankhetkorn S; Teodori E; Garnier-Suillerot A
    Chem Biol Interact; 1999 Jul; 121(2):125-40. PubMed ID: 10418960
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential effects of verapamil and quinine on the reversal of doxorubicin resistance in a human leukemia cell line.
    Bennis S; Ichas F; Robert J
    Int J Cancer; 1995 Jul; 62(3):283-90. PubMed ID: 7628869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.